|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02877 SHINEWAY PHARM
Nominal 
9.930 +0.190 (+1.951%) Ranking Overview
Ranking based on 3 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
3
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 128.00 RMB (cts) | |
| Net Profit | 969.51 RMB (MIL) | DPS | 42.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 1,031.00 | 136.00 | 52.00 | -- | 1,120.11 | 1,022.00 |
| 2025 | 1,113.00 | 146.00 | 57.90 | -- | 1,246.17 | 1,102.00 |
| 2026 | 1,276.00 | 169.00 | 64.50 | -- | 1,433.54 | 1,240.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 1,031.00 | 136.00 | -- | CHINA RENAISSANCE | Buy | 18.00 | 03/09/2024 | |
| 2024 | 1,120.11 | 148.00 | -- | JEFFERIES HK | Buy | 18.00 | 03/09/2024 | |
| 2024 | 1,022.00 | 123.50 | 52.00 | CCBI | OutPerform | 10.00 | 13/11/2024 | |
| 2025 | 1,246.17 | 165.00 | -- | JEFFERIES HK | -- | -- | 03/09/2024 | |
| 2025 | 1,102.00 | 146.00 | -- | CHINA RENAISSANCE | -- | -- | 03/09/2024 | |
| 2025 | 1,113.00 | 134.60 | 57.90 | CCBI | -- | -- | 13/11/2024 | |
| 2026 | 1,433.54 | 190.00 | -- | JEFFERIES HK | -- | -- | 03/09/2024 | |
| 2026 | 1,276.00 | 169.00 | -- | CHINA RENAISSANCE | -- | -- | 03/09/2024 | |
| 2026 | 1,240.00 | 149.90 | 64.50 | CCBI | -- | -- | 13/11/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 24/12/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 626,479 |
| %Change | 27.472% |
| EPS / (LPS) | RMB 0.830 |
| NBV Per Share (¥) | RMB 8.871 |